1 - 8 of 8 articles
When patients seek treatment, they are supposed to receive “informed consent,” but the actual rules are governed by state law, according to the Legal Action Center. We wondered about this when a recent unscientific survey of residential treatment programs showed that many do not provide...
Leaders of substance use treatment programs will often refer to the concept of a lifelong recovery journey, but many do little more than pay lip service to it. A new study published last month in the Journal of Psychosocial Rehabilitation and Mental Health uses information from in‐depth...
First it was the plant, cannabis. How could this be made into a saleable profit‐making commodity when it grows in the ground? Witness the marijuana (a chemical from the plant) industry, which lobbied to make sure laws in states that legalized it banned people from growing more than a few plants.
Xylazine, a veterinary drug for sedation, is not approved by the Food and Drug Administration (FDA) for humans. A central nervous system depressant, it has been used as a toxic adulterant in illicit fentanyl and heroin, and it may increase the risk of fatal overdose. It's not an opioid, so...
The American Medical Association (AMA) is telling states to halt the use of prior authorizations for opioid use disorder (OUD) treatment and to provide adequate pain relief via opioid prescriptions. These recommendations are needed to stem the continuing increases in opioid overdoses, according...
Some clarification on the use of marijuana in the Olympics: The World Anti‐Doping Agency (WADA) has endorsed the decision of its Prohibited List Expert Advisory Group to initiate in 2022 a scientific review of the status of cannabis. Currently, cannabis is prohibited “in competition only,” WADA...
When the American Academy of Pediatrics (AAP) released its clinical report “Identification and Management of Eating Disorders in Children and Adolescents” in the Jan. 2021 issue of Pediatrics, most families were preoccupied, as they still are, with COVID‐19. Providers who treat substance use...
Virtual and in‐person: The European College of Neuropsychopharmacology Congress will be held Oct. 2‐5 in Lisbon, Portugal. For more information, go to https://www.ecnp.eu/ecnpcongress/congresses
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Sign Up Log In
To subscribe to email alerts, please log in first, or sign up for a DeepDyve account if you don’t already have one.
To get new article updates from a journal on your personalized homepage, please log in first, or sign up for a DeepDyve account if you don’t already have one.